GlassScriptPhysician profile
Albert Elhiani
NPI 1699298539
$10,393.81
in general payments reported to CMS, 2019-2025
29 companies · $1,648 in 2025
The $1,648 reported for 2025 was more than what 80% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,472 · 2020: $1,595 · 2021: $1,532 · 2022: $820 · 2023: $1,395 · 2024: $1,933 · 2025: $1,648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,525 · Travel and Lodging: $1,175 · Education: $276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,524.82 |
| Travel and Lodging | $1,175.40 |
| Education | $275.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,349.34 | 2020-2025 | Prostep, Prostep Mica, N/A |
| Smith+Nephew, INC. | $1,204.90 | 2021-2025 | Collagenase Santyl, Regranex |
| Micromed INC | $917.77 | 2020 | |
| Acell, INC. | $903.33 | 2019-2020 | |
| Arthrex, INC. | $874.71 | 2024 | |
| Integra Lifesciences Corporation | $698.74 | 2019-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Paratek Pharmaceuticals, INC. | $571.01 | 2023-2025 | Nuzyra |
| Organogenesis INC. | $522.29 | 2023-2024 | Puraply |
| Biotissue Holdings INC. | $394.04 | 2022-2024 | |
| Wright Medical Technology, INC. | $290.64 | 2019-2020 | |
| Crossroads Extremity Systems, LLC | $166.22 | 2019 | |
| Paragon 28, INC. | $139.83 | 2021 | |
| Cardiovascular Systems INC. | $138.54 | 2021 | |
| Celularity INC. | $137.58 | 2020 | |
| Kci USA, INC. | $135.26 | 2019-2023 | Activ.A.C., V.A.C. Veraflo, V.A.C.Ulta |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $133.23 | 2019-2023 | |
| Bone Support INC. | $127.72 | 2024 | Cerament G, Ceramentbone Void Filler |
| Amgen INC. | $121.58 | 2024 | Krystexxa |
| Nevro Corp. | $113.97 | 2024 | Senza |
| Horizon Therapeutics Plc | $98.55 | 2023 | Krystexxa |
| Medical Device Business Services, INC. | $86.06 | 2020-2023 | |
| Averitas Pharma INC. | $66.37 | 2025 | Qutenza |
| Solventum Corporation | $44.20 | 2024 | Activ.A.C., Promogran Prisma |
| Depuy Synthes Sales INC. | $39.89 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $30.42 | 2025 | |
| Kerecis Limited | $29.46 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Nvision Biomedical Technologies, INC. | $22.62 | 2022 | |
| Bioventus LLC | $20.96 | 2024 | Exogen Ultrasound Bone Healing System |
| Orthofix Medical, INC. | $14.58 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Elhiani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.